Read more

May 07, 2020
1 min read
Save

AAOS, OREF establish partnership for clinical research in musculoskeletal care

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The American Academy of Orthopaedic Surgeons and the Orthopaedic Research and Education Foundation announced a strategic partnership to help narrow the gap between clinical research funding and prioritized clinical research needs in musculoskeletal care, according to a press release.

The release noted the partnership aims to highlight areas of clinical research where there is a need for increased, targeted funding to evaluate the effectiveness of various orthopedic interventions and ultimately improve the quality of care for patients. The AAOS included research addressing the efficacy of biologics for treatment of orthopedic diseases with a focus on platelet-rich plasma and growth factor injections for full-thickness rotator cuff tears and osteoarthritis of the knee on the inaugural list of clinical research topics, according to the release. Funding for clinical research that reviews the effect of tobacco, vaping and/or marijuana use on postoperative outcomes for total joint arthroplasty, as well as the effectiveness of antibiotic bone cement for prevention of periprosthetic joint infections have also been prioritized by the AAOS. The release noted the selection of topics will be finalized by the Orthopaedic Research and Education Foundation (OREF) Research Grants Committee in the request for applications, which is scheduled to be released later this year.

Kristy Weber
Kristy Weber

“Orthopedic surgeons rely on the AAOS clinical practice guidelines to provide high-quality, unbiased evidence-based recommendations for a variety of musculoskeletal treatments. However, there are several orthopedic interventions for which there is a dearth of evidence evaluating their effectiveness,” Kristy Weber, MD, FAAOS, past president of the AAOS, said in the release. “Together with our partners at OREF, we have designed a unique funding opportunity for clinical researchers looking to design and execute studies across musculoskeletal specialties, including orthobiologics. To help jump-start the effort in 2020, the AAOS is making an initial financial investment.”

 

Reference:

www.aaos.org/aaos-home/newsroom/press-releases/aaos-and-oref-announce-strategic-partnership/